Skip to main content

Table 2 Characteristics of the acute ischemic stroke or TIA cohort by survival at the end of the follow-up period

From: Heart dysfunction in patients with acute ischemic stroke or TIA does not predict all-cause mortality at long-term follow-up

  Non-survivors Survivors P-values
n = 132 n = 39 n = 93  
Age (mean ± SD) 77.5 ± 6.8** 71.5 ± 9.6 0.001
Stroke (%) 97.4* 80.6 0.012
TIA (%) 2.6* 19.4 0.012
mRS at 3-months follow-up    
  ≤2 (%) 69.2** 91.3 0.001
  >2 (%) 30.8** 8.7 0.001
Laboratory variables    
  CRP (mg/L) 28.0 ± 48.9* 11.4 ± 21.2 0.012
Echocardiogram parameters    
  LVEF 55.0 ± 12.3* 58.8 ± 8.2 0.043
Cardiovascular risk factors    
  Smoking (%) 29.6** 9.1 0.009
Cardiovascular diseases    
  Myocardial infarction (%) 28.2* 10.8 0.012
  Angina pectoris (%) 25.6* 11.8 0.048
Comorbidity    
  eGFR <60 (mL/min) (%)1 47.2* 26.1 0.023
  Anaemia (%)2 21.1* 7.8 0.033
Pre-stroke medication    
  Clopidogrel (%) 5.1* 0.0 0.028
Post-stroke medication    
  Aspirin (%) 71.1* 87.1 0.029
  1. Only variables that are significant are listed in the table.
  2. mRS, Modified rankin scale; CRP, C-reactive protein; LVEF, left ventricular ejection fraction; eGFR, estimated glomerular filtration rate.
  3. 1eGFR estimated by Cockcroft-Gault formula.
  4. 2Anaemia according to WHO definition, as hemoglobin <130 g/L (males) and hemoglobin <120 g/L (females).
  5. *, P < 0.05; **, P < 0.01 non-survivors compared with survivors.